Vaginal, endometrial, and reproductive hormone findings: Randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: The Herbal Alternatives for Menopause (HALT) Study

Menopause

Volumn 15, Issue 1, 2008, Pages 51-58

  Reed, Susan D ^a,b,c,d   Newton, Katherine M ^a   LaCroix, Andrea Z ^a,c   Grothaus, Louis C ^a   Grieco, Verena S ^b   Ehrlich, Kelly ^a  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Endometrium; Herbs; Menopause; Reproductive hormones; Vagina Y Black cohosh

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; CONJUGATED ESTROGEN; ESTRADIOL; FOLLITROPIN; GLOBULIN; HERBACEOUS AGENT; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PLACEBO; SEX HORMONE;

ADULT; ANGELICA SINENSIS; ARTICLE; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ELEUTHEROCOCCUS SENTICOSUS; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLYCYRRHIZA GLABRA; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; OAT; POMEGRANATE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERUS; VAGINA; VAGINA CYTOLOGY; VAGINA EPITHELIUM; VAGINAL DRYNESS; VASOMOTOR DISORDER; VITEX AGNUS CASTUS;

CIMICIFUGA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HOT FLASHES; HUMANS; ISOFLAVONES; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; VAGINA; VASOMOTOR SYSTEM;

EID: 38049012384     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318057787f     Document Type: Article

References (27)

1. Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczvk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003;10:507-515.
2. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormonal therapy or placebo: a randomized trial. Ann Intern Med 2006;145:869-879.
3. Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006;24:2836-2841.
4. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739-2745.
5. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneickevon Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005;105:1074-1083.
6. Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer C, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005;51:397-404.
7. Wuttke W, Raus K, Gorkow C. Efficacy and tolerability of the black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study. Maturitas 2006;55(Suppl 1):S83-S91.
8. Verhoeven MO, van der Mooren MJ, van de Weijer PH, et al. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 2005;12:412-420.
9. Blumenthal M. Garlic is top-selling herb; herb combinations see increase. Available at: http://www.herbalgram.org/herbalgram/articleview. Accessed July 10, 2006.
10. Wuttke W, Gorkow C, Seidlova-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause 2006;13:185-196.
11. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002;11:163-174.
12. Lehmann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa in German. Zentralbl Gynakol 1988;110:611-618.
13. Nesselhut T, Liske E. Pharmacological measures in postmenopausal women with an isopropanolic aqueous extract of Cimicifuga racemosa rhizoma [abstract]. Presented at: 10th Annual Meeting of The North American Menopause Society, New York, NY, September 1999.
14. Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke D. Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol 2002;83:133-147.
15. Seidlova-Wuttke D, Hesse O, Jarry H, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17β. Eur J Endocrinol 2003;149:351-362.
16. Newton KM, Reed SD, Grothaus L, et al. Herbal Alternatives for Menopause (HALT) Study: background and study design. Maturitas 2005;52:134-146.
17. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
18. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
19. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003;289:3243-3253.
20. Korhonen MO, Symons JP, Hyde BM, Rowan JP, Wilborn WH. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am J Obstet Gynecol 1997;176:377-380.
21. Gol K, Saracoglu F, Ekici A, Sahin I. Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women. Gynecol Endocrinol 2001;15:63-67.
22. Kaari C, Haidar MA, Junior JM, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006;53:49-58.
23. Stoll W. Phytopharmacon influence atrophic vaginal epithelium: double-blind study of Cimicifuga vs. estrogenic substances. Therapeutikon 1987;1:23-31.
24. Raus K, Brucker C, Gorkow C, Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 2006;13:678-691.
25. De Smet P. Herbal medicine in Europe - relaxing regulatory standards. N Engl J Med 2005;352:1176-1179.
26. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-1575.
27. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005;11:42-49.